Feasibility of intranasal human milk as stem cell therapy in preterm infants with intraventricular hemorrhage.
Journal
Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884
Informations de publication
Date de publication:
30 Apr 2024
30 Apr 2024
Historique:
received:
07
12
2023
accepted:
17
04
2024
revised:
15
04
2024
medline:
1
5
2024
pubmed:
1
5
2024
entrez:
30
4
2024
Statut:
aheadofprint
Résumé
Intraventricular hemorrhage (IVH) is a common cause of preterm brain injury. Fresh parent's own milk (POM) contains pluripotent stem cells (SCs) that produce neuronal cells in-vitro. The permeable neonatal blood brain barrier potentially allows SC delivery. We performed the first prospective trial (clinicaltrials.gov NCT04225286) of feasibility of intranasal POM (IPOM) in preterm infants with IVH and described SC content of POM samples. 37 Infants (mean gestation 27.7 ± 2.6 weeks, birthweight 1030 ± 320 g) with IVH (35.1% grade IV) were recruited from two tertiary Toronto NICUs. IPOM was given ideally twice daily until 28 days of age. Tolerance and adverse reactions were collected and 162 administering providers surveyed. There were no major adverse reactions. Provider surveys suggested acceptability, although potential provider and subject stress requires further study. Milk cell analysis suggests wide variability between parents. This phase 1 study demonstrated IPOM was tolerated and feasible in preterm infants.
Identifiants
pubmed: 38688998
doi: 10.1038/s41372-024-01982-8
pii: 10.1038/s41372-024-01982-8
doi:
Banques de données
ClinicalTrials.gov
['NCT04225286']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Références
Mukerji A, Shah V, Shah PS. Periventricular/intraventricular hemorrhage and neurodevelopmental outcomes: a meta-analysis. Pediatrics. 2015;136:1132–43.
doi: 10.1542/peds.2015-0944
pubmed: 26598455
Ahn SY, Chang YS, Park WS. Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage. Korean J Pediatr. 2014;57:251–6.
doi: 10.3345/kjp.2014.57.6.251
pubmed: 25076969
pmcid: 4115065
Briere C, McGrath J, Jensen T, Matson A, Finck C. Breast milk stem cells: current science and implications for preterm infants. Adv Neonatal Care. 2016;16:410–9.
doi: 10.1097/ANC.0000000000000338
pubmed: 27749687
Cotten CM, Murtha AP, Goldberg RN, Grotegut CA, Smith PB, Goldstein RF, et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr. 2014;164:973–979.e1.
doi: 10.1016/j.jpeds.2013.11.036
pubmed: 24388332
Mitsialis SA, Kourembanas S. Stem cell–based therapies for the newborn lung and brain: possibilities and challenges. Semin Perinatol. 2015;40:138–51.
doi: 10.1053/j.semperi.2015.12.002
Mukai T, Mori Y, Shimazu T, Takahashi A, Tsunoda H, Yamaguchi S, et al. Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in a neonatal intraventricular hemorrhage model. Neuroscience. 2017;355:175–87.
doi: 10.1016/j.neuroscience.2017.05.006
pubmed: 28504197
Park WS, Ahn SY, Sung SI, Ahn J, Chang YS. Mesenchymal stem cells: the magic cure for intraventricular hemorrhage? Cell Transpl. 2017;26:439–48.
doi: 10.3727/096368916X694193
Twigger A, Hodgetts S, Filgueira L, Hartmann PE, Hassiotou F. From breast milk to brains. J Hum Lact. 2013;29:136–9.
doi: 10.1177/0890334413475528
pubmed: 23515086
Nabetani M, Shintaku H, Hamazaki T. Future perspectives of cell therapy for neonatal hypoxic–ischemic encephalopathy. Pediatr Res. 2018;83:356–63.
doi: 10.1038/pr.2017.260
pubmed: 29016557
Hosseini SM, Talaei-Khozani T, Sani M, Owrangi B. Differentiation of human breast-milk stem cells to neural stem cells and neurons. Neurol Res Int. 2014;2014:807896–8.
doi: 10.1155/2014/807896
pubmed: 25506428
pmcid: 4260437
Keller T, Wengenroth L, Smorra D, Probst K, Kurian L, Kribs A, et al. Novel DRAQ5™/SYTOX® blue based flow cytometric strategy to identify and characterize stem cells in human breast milk. Cytom B Clin Cytom. 2019;96:480–9.
doi: 10.1002/cyto.b.21748
Hassiotou F, Geddes DT, Hartmann PE. Cells in human milk. J Hum Lact. 2013;29:171–82.
doi: 10.1177/0890334413477242
pubmed: 23515088
Aydin MS, Yigit EN, Vatandaslar E, Erdogan E, Ozturk G. Transfer and integration of breast milk stem cells to the brain of suckling pups. Sci Rep. 2018;8:14289–9.
doi: 10.1038/s41598-018-32715-5
pubmed: 30250150
pmcid: 6155265
Kersin SG, Özek E. Breast milk stem cells: are they magic bullets in neonatology? Turk Arch Pediatr. 2021;56:187–91.
doi: 10.5152/TurkArchPediatr.2021.21006
pubmed: 34104907
pmcid: 8152646
Keller T, Körber F, Oberthuer A, Schafmeyer L, Mehler K, Kuhr K, et al. Intranasal breast milk for premature infants with severe intraventricular hemorrhage—an observation. Eur J Pediatr. 2019;178:199–206
doi: 10.1007/s00431-018-3279-7
pubmed: 30386923
Li Y, Wu H, Jiang X, Dong Y, Zheng J, Gao J. New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery. Acta Pharm Sin B. 2022;12:3215–32.
doi: 10.1016/j.apsb.2022.04.001
pubmed: 35967290
pmcid: 9366301
Herman S, Fishel I, Offen D. Intranasal delivery of mesenchymal stem cells‐derived extracellular vesicles for the treatment of neurological diseases. Stem Cells. 2021;39:1589–1600.
doi: 10.1002/stem.3456
pubmed: 34520591
Borhani-Haghighi M, Navid S, Mohamadi Y. The therapeutic potential of conditioned medium from human breast milk stem cells in treating spinal cord injury. Asian Spine J. 2020;14:131–8.
doi: 10.31616/asj.2019.0026
pubmed: 31711062
Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am. 2013;60:49–74.
doi: 10.1016/j.pcl.2012.10.002
pubmed: 23178060
pmcid: 3586783
Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529–34.
doi: 10.1016/S0022-3476(78)80282-0
pubmed: 305471
Hassiotou F, Hartmann PE. At the dawn of a new discovery: the potential of breast milk stem cells. Adv Nutr. 2014;5:770–8.
doi: 10.3945/an.114.006924
pubmed: 25398739
pmcid: 4224213